Medvisis Switzerland AG
- Biotech or pharma, therapeutic R&D
Medvisis Switzerland AG is a Pharmaceutical company focused on in-licencing innovative rare disease, specialty and hospital products and commercializing them in the Swiss market (product registration, pricing & reimbursement, commercialization. The company consists of Senior executives (incl. National Sales & Marketing Heads of top5 Pharma companies, a formal Hospital Head, a former Board Member of the Swiss national pharma loby)) that gives Medvisis outstading access to Swiss KOLs, national and local payers as well as other critical healthcare decision makers. In addition, the company has a special licence that allows the import and distribution of new innovative products with high unmet medical need directly upon FDA (or other accredited authority) approval. Switzerland is a highly attractive market due to its affluency and excellent infrastructure (reimbursement & pricing, healthcare access).
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}